Tomo Nozawa Selected Research

Tomo Nozawa Research Topics

Disease

5	Juvenile Arthritis (Juvenile Idiopathic Arthritis) 06/2022 - 01/2013
4	Cryopyrin-Associated Periodic Syndromes 01/2024 - 01/2012
4	Arthritis (Polyarthritis) 01/2023 - 01/2015
4	Inflammation (Inflammations) 01/2015 - 01/2012
3	Infections 05/2019 - 01/2012
3	Mucocutaneous Lymph Node Syndrome (Kawasaki Disease) 01/2018 - 04/2012
3	Fever (Fevers) 01/2015 - 01/2012
2	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2024 - 01/2015
2	Aneurysm (Aneurysms) 11/2017 - 04/2012
2	Rheumatic Diseases (Rheumatism) 05/2016 - 01/2012
2	Systemic Lupus Erythematosus (Libman-Sacks Disease) 03/2015 - 01/2015
1	Wounds and Injuries (Trauma) 02/2021
1	Disease Progression 05/2019
1	Chickenpox 05/2019
1	Tuberculosis (Tuberculoses) 05/2016
1	Lupus Nephritis 03/2015
1	Muscular Diseases (Myopathy) 05/2014
1	Neoplasms (Cancer) 01/2014
1	Leukemia 01/2014
1	Macrophage Activation Syndrome 01/2014
1	Leukocytosis (Pleocytosis) 01/2014
1	Drug-Related Side Effects and Adverse Reactions 05/2013
1	Sacroiliac Arthritis 01/2013
1	Spondylitis 01/2013
1	Neck Pain (Cervicalgia) 01/2013
1	Polymyositis 01/2013
1	Pain (Aches) 01/2013
1	Arthralgia (Joint Pain) 01/2013
1	Spondylarthritis (Spinal Arthritis) 01/2013
1	Axial Spondyloarthritis 01/2013
1	Communicable Diseases (Infectious Diseases) 01/2012
1	Disseminated Intravascular Coagulation 01/2012
1	Gastroenteritis 01/2012
1	Nasopharyngitis 01/2012
1	Respiratory Tract Infections (Respiratory Tract Infection) 01/2012
1	Pyoderma Gangrenosum 12/2008

Drug/Important Bio-Agent (IBA)

5	tocilizumab (atlizumab)FDA Link 05/2019 - 01/2013
4	canakinumab FDA Link 01/2024 - 01/2012
4	Infliximab (Remicade)FDA Link 01/2018 - 12/2008
3	C-Reactive ProteinIBA 01/2023 - 04/2012
3	CytokinesIBA 01/2015 - 01/2012
3	SteroidsIBA 01/2014 - 01/2012
2	InterleukinsIBA 01/2024 - 05/2013
2	Interleukin-18 (Interleukin 18)IBA 06/2022 - 05/2019
2	Methotrexate (Mexate)FDA LinkGeneric 02/2021 - 01/2014
2	Interleukin-6 (Interleukin 6)IBA 05/2019 - 01/2014
2	Immunosuppressive Agents (Immunosuppressants)IBA 05/2016 - 01/2013
2	Mycophenolic Acid (Cellcept)FDA LinkGeneric 03/2015 - 01/2015
2	Adrenal Cortex Hormones (Corticosteroids)IBA 03/2015 - 12/2008
2	Monoclonal AntibodiesIBA 01/2015 - 12/2008
2	AntibodiesIBA 05/2014 - 01/2014
2	Methylprednisolone FDA LinkGeneric 05/2014 - 01/2014
2	Ferritins (Ferritin)IBA 01/2014 - 01/2012
2	Cyclosporine (Ciclosporin)FDA LinkGeneric 01/2012 - 12/2008
1	Interleukin-1 (Interleukin 1)IBA 01/2024
1	Biomarkers (Surrogate Marker)IBA 01/2023
1	p38 Mitogen-Activated Protein KinasesIBA 06/2022
1	GlucocorticoidsIBA 02/2021
1	Analgesics (Analgesic Drugs)IBA 02/2021
1	Prednisone (Sone)FDA LinkGeneric 02/2021
1	GoldIBA 05/2016
1	InterferonsIBA 05/2016
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 05/2014
1	Signal Recognition ParticleIBA 05/2014
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2014
1	fibrin fragment D (D-dimer)IBA 01/2014
1	Pyrin Domain-Containing 3 Protein NLR FamilyIBA 05/2013
1	Fructose-Bisphosphate Aldolase (Aldolase)IBA 01/2013
1	HLA-B27 Antigen (HLA B27 Antigen)IBA 01/2013
1	Adalimumab (Humira)FDA Link 01/2013
1	Intravenous Immunoglobulins (IVIG)FDA Link 04/2012
1	PalmitatesIBA 01/2012
1	Antiviral Agents (Antivirals)IBA 01/2012
1	Aspartate Aminotransferases (Aspartate Transaminase)IBA 01/2012
1	Dexamethasone (Maxidex)FDA LinkGeneric 01/2012
1	Immunologic Factors (Immunomodulators)IBA 01/2012
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 01/2012
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 12/2008
1	Prednisolone (Predate)FDA LinkGeneric 12/2008

Therapy/Procedure

8	Therapeutics 05/2019 - 04/2012
1	Plasma Exchange 05/2014